1. Home
  2. LEXX vs BGFV Comparison

LEXX vs BGFV Comparison

Compare LEXX & BGFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • BGFV
  • Stock Information
  • Founded
  • LEXX 2004
  • BGFV 1955
  • Country
  • LEXX Canada
  • BGFV United States
  • Employees
  • LEXX N/A
  • BGFV N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • BGFV Other Specialty Stores
  • Sector
  • LEXX Health Care
  • BGFV Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • BGFV Nasdaq
  • Market Cap
  • LEXX 49.3M
  • BGFV 46.6M
  • IPO Year
  • LEXX N/A
  • BGFV N/A
  • Fundamental
  • Price
  • LEXX $3.19
  • BGFV $2.05
  • Analyst Decision
  • LEXX Strong Buy
  • BGFV
  • Analyst Count
  • LEXX 2
  • BGFV 0
  • Target Price
  • LEXX $11.00
  • BGFV N/A
  • AVG Volume (30 Days)
  • LEXX 100.1K
  • BGFV 218.0K
  • Earning Date
  • LEXX 11-18-2024
  • BGFV 10-29-2024
  • Dividend Yield
  • LEXX N/A
  • BGFV 9.76%
  • EPS Growth
  • LEXX N/A
  • BGFV N/A
  • EPS
  • LEXX N/A
  • BGFV N/A
  • Revenue
  • LEXX $411,019.00
  • BGFV $829,490,000.00
  • Revenue This Year
  • LEXX $82.02
  • BGFV $2.65
  • Revenue Next Year
  • LEXX $95.09
  • BGFV N/A
  • P/E Ratio
  • LEXX N/A
  • BGFV N/A
  • Revenue Growth
  • LEXX 34.05
  • BGFV N/A
  • 52 Week Low
  • LEXX $0.85
  • BGFV $1.45
  • 52 Week High
  • LEXX $6.85
  • BGFV $8.04
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 48.73
  • BGFV 51.86
  • Support Level
  • LEXX $2.91
  • BGFV $1.96
  • Resistance Level
  • LEXX $3.39
  • BGFV $2.17
  • Average True Range (ATR)
  • LEXX 0.20
  • BGFV 0.14
  • MACD
  • LEXX 0.00
  • BGFV 0.00
  • Stochastic Oscillator
  • LEXX 56.00
  • BGFV 56.67

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

About BGFV Big 5 Sporting Goods Corporation

Big 5 Sporting Goods Corp is a specialty retailer company that is principally engaged in the sale of sporting goods in the Western United States. Its product mix includes athletic shoes, apparel, and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports. The company operates solely as a sporting goods retailer, which includes both its retail stores and an e-commerce platform. The company operates a distribution center located in Riverside, California, that services all of its stores and e-commerce platform.

Share on Social Networks: